Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CS DiagnosticsCSDX Days Sales Outstanding is 0.00 as of Dec. 2025. The stock has 1 warning sign investors should review. Among 810 Medical Devices & Instruments companies, CS Diagnostics ranks worse than 123456.67% on this metric.
The historical rank and industry rank for CS Diagnostics's Days Sales Outstanding or its related term are showing as below:
CSDX's Days Sales Outstanding is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 65.85 * Ranked among companies with meaningful Days Sales Outstanding only.
CS Diagnostics's Days Sales Outstanding
stayed the same
from Sep. 2024 (0.00) to Dec. 2025 (0.00).
CS Diagnostics (OTCPK:CSDX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
CS Diagnostics Days Sales Outstanding Related Terms
CS Diagnostics Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for CS Diagnostics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSDX vs NMTC, IRIX, LFWD: Days Sales Outstanding Comparison
For the Medical Devices subindustry, CS Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CS Diagnostics Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CS Diagnostics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where CS Diagnostics's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CS Diagnostics (CSDX) has a Days Sales Outstanding of 0.00 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CS Diagnostics and its competitors. According to the industry distribution chart, CS Diagnostics ranks #999999 out of 810 companies in the Medical Devices & Instruments industry.
Is CS Diagnostics' Days Sales Outstanding too high?
CS Diagnostics' current Days Sales Outstanding is 0.00. Based on the distribution chart, CS Diagnostics ranks #999999 out of 810 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does CS Diagnostics' Days Sales Outstanding compare to NMTC and IRIX?
According to the Medical Devices & Instruments industry distribution chart, CS Diagnostics ranks #999999 out of 810 companies for Days Sales Outstanding. This places CS Diagnostics in the lower half of its industry. The industry median Days Sales Outstanding is 65.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.85, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CS Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CS Diagnostics's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CS Diagnostics stock overvalued right now?
CS Diagnostics (CSDX) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For CS Diagnostics (CSDX), the current Days Sales Outstanding is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CS Diagnostics Corp is a United States based Corporation, its focus is on improving therapy results and reducing side effects. In addition, it offers international companies in the medical industry access to markets and the service of approval of medical products in Europe and the MENA regions. Furthermore, it develops its own products with the aim of maximizing patient benefit.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSDX has been successfully added to your 
